Binimetinib Market Share, Growth Forecast Global Industry Outlook 2024 - 2034
Binimetinib Market Overview A small molecule inhibitor called binimetinib is used to treat cancer by blocking the activity of mitogen-activated protein kinase (MAPK) kinase (MEK). It is sold under the Mektovi brand. Binimetinib functions by preventing the MAPK signaling pathway's MEK1 and MEK2 proteins from acting. This pathway, which is frequently dysregulated in cancer cells, is...
0 Comments 0 Shares 3K Views 0 Reviews
Sponsored
Sponsored
Sponsored
google-site-verification: google037b30823fc02426.html